Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Mueller

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 24, 2025
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Sabine Mueller, Mariella G Filbin, et al.
Nature Medicine|April 16, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialLindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
JAMA Network Open|October 26, 2019
Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With CancerOlena M Vaske, Isabel Bjork, Sofie R Salama, et al.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.
Cancer Research|May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline gliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Nature|June 10, 2026
A prognostic human brain network for diffuse midline gliomaJai Sidpra, Valentina Lind, Alexander L Cohen, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|January 24, 2025
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Sabine Mueller, Mariella G Filbin, et al.
Nature Medicine|April 16, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialLindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
JAMA Network Open|October 26, 2019
Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With CancerOlena M Vaske, Isabel Bjork, Sofie R Salama, et al.
Cancer Research|May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline GliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.
Cancer Research|May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline gliomaEvangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Nature|June 10, 2026
A prognostic human brain network for diffuse midline gliomaJai Sidpra, Valentina Lind, Alexander L Cohen, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Pageof 23